Stocks
Alnylam Pharmaceuticals (ALNY) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -28.2 | -30.3 | -88.2 | -168.2 | 90.6 | 59.3 | |
| Changes by years, y/y, % | +53% | +7% | +191% | +91% | -154% | |||
Alnylam Pharmaceuticals. EV/EBITDA
Alnylam Pharmaceuticals. EV/EBITDA, changes, %
Alnylam Pharmaceuticals (ALNY) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -229.9 | -246.7 | 313.7 | 107.8 | 68.8 | 59.3 | |
| Changes by years, y/y, % | +72% | -199% | -216% | -164% | -130% | |||
| Changes by quarters, q/q, % | +36% | +7% | -227% | -66% | -36% | |||
